Prokarium

Prokarium is a clinical-stage biopharmaceutical company focused on developing microbial cancer immunotherapies. The company’s products elicit a broad immune response, including mucosal, systemic, and cellular immunity for the treatment of solid tumors, as well as other oral vaccines, enabling physicians to evaluate the safety and immunogenicity of bivalent vaccines.